The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study
NCT05135013 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-11-26
Summary
The aim of the current study is to investigate the association between hormonal intake, occupational and demographic factors, and the risk of breast cancer (BC) among Egyptian females.
Conditions
- Observational Study
Interventions
- DRUG
-
Dydrogesterone Tablets, Norethisterone acetate, Ethinyl estradiol, Drospirenone and ethinyl estradiol
History of hormonal use as follows: 1. Reason for hormonal use: contraception, fertility promotion, Polycystic ovary syndrome (PCOS) 2. Duration of hormonal use 3. Type of hormonal drug used: dose, hormone type, route of administration
Sponsors & Collaborators
-
Ain Shams University
collaborator OTHER -
NewGiza University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-16
- Primary Completion
- 2022-01-31
- Completion
- 2022-03-31
- FDA Drug
- Yes
More Related Trials
-
Role of FGF21 in Breast Cancer
NCT07113418 ·Status: NOT_YET_RECRUITING
-
Hemostatic Profiles of Endocrine Therapies for Breast Cancer
NCT03381963 ·Status: COMPLETED
-
Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
NCT01298362 ·Status: COMPLETED
-
KEEPS Mammographic Density And Breast Health Ancillary Study
NCT02524561 ·Status: COMPLETED ·Phase: NA
-
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NCT00967239 ·Status: UNKNOWN
-
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
NCT05637671 ·Status: UNKNOWN ·Phase: PHASE3
-
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
NCT00253539 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100
NCT02950207 ·Status: UNKNOWN
-
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003771 ·Status: COMPLETED ·Phase: PHASE3
-
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
NCT00316836 ·Status: COMPLETED
-
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291135 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
NCT00859560 ·Status: COMPLETED
-
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
NCT05297617 ·Status: RECRUITING ·Phase: PHASE2
-
Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children
NCT00458588 ·Status: COMPLETED
-
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
NCT00516698 ·Status: COMPLETED
-
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
NCT05103644 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 ·Status: UNKNOWN
-
Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy
NCT00814034 ·Status: COMPLETED
-
Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients
NCT02765373 ·Status: UNKNOWN
-
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
NCT03063619 ·Status: COMPLETED ·Phase: PHASE2
-
eHealth Intervention for Medication Adherence in Breast Cancer Survivors
NCT05324020 ·Status: COMPLETED ·Phase: NA
-
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
NCT06273800 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
NCT00330317 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
NCT04129216 ·Status: COMPLETED ·Phase: PHASE2
-
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
NCT00080756 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2